← All organizations

Presbyopia Therapies, LLC

For profit

Also known as: LENZ THERAP | LENZ Therapeutics | LENZ Therapeutics, Inc

Phase 1 Phase 2 Phase 3 Phase 4

Highest phase reached

Phase 3

First clinical trial

First marketed drug

Last known activity

Jul 31, 2025

Timeline

2010s

Jun 1, 2013
Presbyopia Therapies, LLC— Founded

2020s

Jul 31, 2025
aceclidine— Marketing Organization

Drugs by trial phase (2 distinct, 10 trials)

Phase 3 (2 own, 0 via acquisition)

Indications

Studied for

Presbyopia

Marketed drugs (1)

aceclidine

Recent trials (17)

NCT06270030CollaboratorPhase 1Mar 4, 2024
NCT06045299CollaboratorPhase 3Sep 27, 2023
NCT05936489Study directorPhase 1Jul 6, 2023
NCT05936489Lead sponsorPhase 1Jul 6, 2023
NCT05728944Lead sponsorPhase 3Apr 24, 2023
NCT05728944Study directorPhase 3Apr 24, 2023
NCT05753189Study directorPhase 3Feb 21, 2023
NCT05753189Lead sponsorPhase 3Feb 21, 2023
NCT05656027Lead sponsorPhase 3Dec 19, 2022
NCT05656027Study directorPhase 3Dec 19, 2022
NCT05431543Sponsor investigatorPhase 2Aug 6, 2022
NCT05431543Study directorPhase 2Aug 6, 2022
NCT05431543Lead sponsorPhase 2Aug 6, 2022
NCT05294328Study directorPhase 2May 5, 2022
NCT05294328Lead sponsorPhase 2May 5, 2022

Details

Founded: Coronado, CA, US Jun 1, 2013
Last known activity: Jul 31, 2025